May 29, 2025 8:30am EDT Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders
May 13, 2025 4:30pm EDT Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results
May 07, 2025 8:30am EDT Vivani Medical to Present at the American Association of Pharmaceutical Scientists’ “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop
Apr 16, 2025 8:30am EDT Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
Apr 15, 2025 8:30am EDT Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity
Mar 31, 2025 7:30am EDT Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Mar 26, 2025 7:30am EDT Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing